Biotech grants
Explore grants for biotech companies. This directory brings together funding for therapeutics, diagnostics, platform technologies, bioprocessing and translational research, from health research agencies, national innovation programs, disease foundations and industry partnerships.
Showing 289-312 of 2,745 grants
CDG Josef Ressel Centres
🇦🇹CDG · Austria
Funds applied-research centres through public-industry co-financed long-term partnerships to strengthen real-world implementation.
Estrdad Government Fee Refund Initiative
🇸🇦Monsha'at · Saudi Arabia
Funds Saudi startups by refunding selected government fees and patent-registration costs.
First Factory — December Round (Première Usine, relève décembre)
🇫🇷Bpifrance · France
Funds first-factory scale-up for innovative manufacturers moving toward production readiness.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
🇺🇸NCATS · United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
SekMo — Hiring a Researcher in a Company
🇪🇪ETAg · Estonia
Funds Estonian companies hiring researchers for applied research and experimental development projects.
VFF Early Stage Financing
🇳🇱RVO · Netherlands
Supports early-stage venture financing that helps start-ups turn prototypes into scalable, innovation-driven products.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
NIH SBIR Direct-to-Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NIH SBIR Fast-Track (Omnibus)
🇺🇸NIH · United States
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
NIH SBIR Phase I (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing biomedical and behavioral-health innovations through early technical validation.
NIH SBIR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing validated biomedical innovations through substantial full development execution.
NIH STTR Phase I (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses partnering with nonprofit research institutions to validate biomedical ideas.
NIH STTR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
🇺🇸NIH · United States
Funds small clinical-trial research at undergraduate-focused colleges that get under $6 million a year from NIH.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21)
NIH · United States
Funds the exploratory version of the same theory-and-methods work on complex trait variation, for ideas that need testing before a larger project is justified.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Clinical Trial Pilot Studies
🇺🇸NIH · United States
Funds pilot work that is both necessary and sufficient to plan a later phase II, III or IV trial — with no further studies needed in between.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
🇺🇸NIH · United States
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
NOURISH: Autoimmunity Digital Health Challenge
🇺🇸OADR-ORWH · United States
Awards up to $650,000 across three phases for digital tools tracking autoimmune nutrition.
Prevention and Intervention Approaches for FASD (R34)
🇺🇸NIAAA · United States
Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.
Title X Family Planning Services Grants
🇺🇸HHS · United States
Supports family planning service providers across United States jurisdictions with grants that strengthen sexual health prevention, testing, counseling, and care.